(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TAVALISSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TAVALISSE

ST13

US500000087407547

Class

5

Filing

87407547

Registration

5822266

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

01/11/2025

Trademark type

Combined

Nice classes

5

Filing date

04/11/2017

Registration date

07/30/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/11/2025

Last transaction

01/11/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2018-05-00

First use in commerce

2018-05-00

Drawing code

3

Owner type

03

Owner location

South San Francisco, CA

Examiner

BILLINGS, JOHN

Current location

Historical data usage

Mark description

The mark consists of a circular design comprised of concentric circles in the colors gray, green and orange. The word "TAVALISSE" is to the right of the circular design in stylized green font. The color white is not claimed as a feature of the mark and represents background only.

Holders and representatives

Holders

Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.

Representatives

James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditionsdiseases and disorders

Publications

History of USPTO decisions and trademark events.

46 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/11/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/11/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/11/2025

E815

TEAS SECTION 8 & 15 RECEIVED

08/14/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/30/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/03/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/17/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/17/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/17/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/17/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/17/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

07/30/2019

DOCK

ASSIGNED TO EXAMINER

07/08/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/27/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/26/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/13/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/07/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/07/2019

IUAF

USE AMENDMENT FILED

04/24/2019

EISU

TEAS STATEMENT OF USE RECEIVED

04/24/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/26/2018

EX2G

SOU EXTENSION 2 GRANTED

10/24/2018

EXT2

SOU EXTENSION 2 FILED

10/24/2018

EEXT

SOU TEAS EXTENSION RECEIVED

10/24/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/26/2018

EX1G

SOU EXTENSION 1 GRANTED

04/24/2018

EXT1

SOU EXTENSION 1 FILED

04/24/2018

EEXT

SOU TEAS EXTENSION RECEIVED

04/24/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/24/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/24/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/29/2017

PUBO

PUBLISHED FOR OPPOSITION

08/29/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/09/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/07/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

07/07/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/07/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

07/07/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/07/2017

DOCK

ASSIGNED TO EXAMINER

07/03/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/20/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/19/2017

NWAP

NEW APPLICATION ENTERED

04/14/2017

Continuous trademark protection

Get notified about every new filing that threatens TAVALISSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.